Skip to main content
JETEMA Co.,Ltd. logo

JETEMA Co.,Ltd. — Investor Relations & Filings

Ticker · 216080 ISIN · KR7216080002 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country KR South Korea
Listing KO 216080

About JETEMA Co.,Ltd.

http://www.jetema.com/

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획승인신청)(제테마더톡신주 100단위 (JTM201)의 중국 임상 2상 면제 및 3상 개시 사전미팅 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically concerning a clinical trial application (임상시험 계획 승인신청) for a pharmaceutical product (JTM201). It details the clinical trial phase, purpose, and regulatory status with the Chinese NMPA. Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2023-11-14 Korean
투자판단관련주요경영사항(JTM201 100단위의 미간주름개선 품목허가 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Major Management Matter' disclosure regarding a product approval application (JTM201) to the Ministry of Food and Drug Safety. It details clinical trial results and regulatory status. Since it does not fit into specific categories like financial reports, M&A, or dividends, and is a standard regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2023-10-31 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, purpose (operating funds), and board approval date. This falls under financing activities and capital structure changes, which aligns with the 'Capital/Financing Update' category.
2023-10-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). It details the specific bond series, acquisition amount, reason (put option exercise), and method of settlement. This type of filing relates to changes in the company's capital structure and debt obligations, which falls under the 'Capital/Financing Update' category.
2023-10-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) for a previously filed stock option grant. This document details changes to the number of recipients and the total number of shares granted due to employee departures. In the context of financial filings, reports regarding stock option grants, especially those involving amendments to previous filings, are classified under 'Regulatory Filings' (RNS) as they represent specific corporate disclosures to regulatory bodies that do not fall into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2023-10-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2023-09-27 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.